Depression among patients with HIV/AIDS: A treatment dilemma

Journal of Pharmacy Practice

Volumn 14, Issue 6, 2001, Pages 540-550

  Overman, Gerald P ^a   Anderson, Stacey L ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antidepressant; Depression; HIV; Substance abuse

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; EFAVIRENZ; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MIRTAZAPINE; NEFAZODONE; NEVIRAPINE; NORTRIPTYLINE; PAROXETINE; RITONAVIR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MENTAL DISEASE; OPPORTUNISTIC INFECTION; PREVALENCE; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SUBSTANCE ABUSE; SYMPTOMATOLOGY; VIRUS INFECTION;

EID: 0035198054     PISSN: 08971900     EISSN: None     Source Type: Journal    
DOI: 10.1177/089719001129040883     Document Type: Review

References (52)

1. Psychological impact of HIV disease and implications for intervention
2. Psychotherapies for the person with HIV disease
3. Substance abuse and HIV infection
4. Stress and depressive symptoms prospectively predict immune change among HIV-seropositive men
5. Neurological manifestations of HIV infection
6. Prevalence and treatment of depressive disorders in HIV illness
7. Psychiatric disorder in HIV infection
8. Mood disorders in HIV infection: Prevalence and risk factors in a non-epicenter of the AIDS epidemic
9. An assessment of rates of psychiatric morbidity and functioning in HIV disease
10. A prospective study of psychiatric aspects of early HIV disease in women
11. Prevalence of psychiatric disorders in early stages of HIV infection
12. Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men
13. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men
14. Depressive affect and survival among gay and bisexual men infected with HIV
15. Progression to AIDS: The effects of stress, depressive symptoms, and social support
16. Disease progression in HIV-positive women with moderate to severe immunosuppression: The role of depression
17. Depression in the context of human immunodeficiency virus infection: Implications for treatment
18. Stability of mood despite HIV illness progression in a group of homosexual men
19. WHO Neuropsychiatric AIDS Study, cross sectional phase I. Study design and psychiatric findings
20. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection III: Neurological and neuropsychological findings
21. Psychiatric side effects from medical drugs
22. Depression in the medically ill. Management considerations
23. Somatic symptoms and HIV infection: Relationship to depressive symptoms and indicators of HIV disease
24. Somatic complaints associated with depressive symptoms in HIV-positive patients
25. Major depressive disorder and HIV-1 infection: A review of treatment trials
26. Depression in patients with HIV infection
27. Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness
28. Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients
29. Treatment of depressive symptoms in human immunodeficieny virus-positive patients
30. Effects of methylphenidate in HIV-related depression: A comparative trial with desipramine
31. Effect of imipramine on depression and immune status in a sample of men with HIV infection
32. Treatment of major depression in HIV-seropositive men
33. Fluoxetine treatment for depression in patients with HIV and AIDS: A randomized, placebo-controlled trial
34. Structured group therapy and fluoxetine to treat depression in HIV-positive persons
35. Effects of fluoxetine on mood and immune status in depressed patients with HIV illness
36. A report of eight HIV-seropositive patients with major depression responding to fluoxetine
37. Fluoxetine treatment of depressed patients with HIV infection
38. Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS
39. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: An open trial of nefazodone
40. Effects of sertraline on mood and immune status in patients with major depression and HIV illness: An open trial
41. Notes on the use of fluvoxamine as treatment of depression in HIV-1 infected subjects
42. Depression in patients with HIV infection
43. Major depressive disorder and HIV-1 infection: A review of treatment trials
44. Significant interactions with new antiretrovirals and psychotropic drugs
45. Update: Clinically significant cytochrome P-450 drug interactions
46. Serotonin selective reuptake inhibitor drug interactions and the cytochrome P450 system
47. Substance use disorders in gay/bisexual men with HIV and AIDS
48. Current concepts in the treatment of depression in alcohol dependent patients
49. Prevalence and treatment models for addiction in psychiatric populations
50. The pharmacotherapy of dual diagnosis
51. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes